Related Experiment Videos
Enzyme immunoassays (EIAs) of eicosanoids
1Department of Cell Biology, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford, USA.
Methods in Molecular Biology (Clifton, N.J.)
|May 27, 1999
Summary
Enzyme immunoassays (EIAs) offer a sensitive, nonradioactive method for measuring eicosanoids in biological samples. While cost-effective for routine use, EIA effectiveness depends on available commercial reagents and precise laboratory techniques.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Background:
- Eicosanoids are crucial signaling molecules involved in various physiological and pathological processes.
- Enzyme immunoassay (EIA) provides a sensitive, nonradioactive method for quantifying eicosanoids in biological samples.
- While commercial assay kits are available, in-house development can be more economical for routine use.
Purpose of the Study:
- To outline the principles and practical considerations of enzyme immunoassays for eicosanoid quantification.
- To discuss the advantages and limitations of EIA in biological sample analysis.
- To assess the economic feasibility and technical requirements for implementing EIA in a laboratory setting.
Main Methods:
- Enzyme immunoassay (EIA) utilizing enzyme-tracers and antibodies for eicosanoid detection.
- Precise pipetting techniques and adherence to critical assay procedures are essential.
- Utilizing commercially available assay kits or developing in-house reagents.
Main Results:
- EIA is a highly sensitive and nonradioactive method for determining eicosanoid concentrations.
- In-house assay development is more economical for routine applications.
- The primary limitation is the availability of specific enzyme-tracers and antibodies for certain eicosanoids.
Conclusions:
- EIA is a valuable tool for eicosanoid measurement, offering sensitivity and cost-effectiveness for routine use.
- Successful implementation requires meticulous technique and careful consideration of reagent availability.
- Most biologically significant eicosanoids have commercially available antibodies and enzyme-tracers, facilitating EIA application.